Yun Shen
About Yun Shen
Yun Shen is an Associate Director Biostatistician at Bristol-Myers Squibb with over 17 years of experience, specializing in Phase I-III clinical trials and fields such as immuno-oncology, oncology, and immunology.
Title and Current Role
Yun Shen currently serves as Associate Director Biostatistician at Bristol-Myers Squibb. In this capacity, Yun Shen utilizes extensive biostatistical expertise to contribute to the development and evaluation of clinical trials. This role involves collaboration across various departments to ensure the successful execution of Phase I-III clinical trials.
Professional Background
Yun Shen has accumulated over 17 years of experience in the biostatistics field. Prior to joining Bristol-Myers Squibb in January 2006, Yun Shen worked as a Consultant Biostatistician at GSK from 2004 to 2006. Throughout the career, Yun Shen has focused extensively on clinical trials, with a specialization in Phase I-III trials. This extensive background has provided Yun with a robust foundation in both early and late-phase clinical research.
Education and Expertise
Yun Shen holds a Ph.D. in Applied Statistics from the University of California, Riverside, which was completed in 2004. This advanced degree followed a Bachelor's degree from Fudan University, achieved in 1998. Throughout the educational journey, Yun Shen developed a strong statistical acumen that has underpinned a successful career in biostatistics, particularly in the fields of immuno-oncology, oncology, and immunology.
Specializations
Yun Shen specializes in the design, execution, and analysis of Phase I-III clinical trials. This expertise is particularly pronounced in the areas of immuno-oncology, oncology, and immunology. Through work at both GSK and Bristol-Myers Squibb, Yun Shen has gained considerable experience in early to late-phase clinical trials, ensuring ethical standards and robust statistical methodologies are adhered to in the process.